Page 755 - Clinical Application of Mechanical Ventilation

Index 721

Beta receptors, 424t C
Bi-Flex, 205, 205f
Bilevel positive airway pressure (BiPAP), 91–92, 195t Caffeine, 428
common interfaces for, 198–203 Calcium, 434, 701
titration of, 204–205, 205t Caloric requirements, 407
use of, 197 CaO 2 , 17
Biopsy, 471t Capnography, 194, 261
Biphasic positive airway pressure (BiPAP), 112–113, clinical application, 261–263
113f limitations of, 264
Birth weight, 556, 557t waveforms, 261–263, 263f
Bitolterol, 425t Carbon dioxide, 43
Bivona Fome-Cuf, 155–156 detection device, 166
Blind distal end, 130 end-tidal carbon dioxide monitoring, 260–265
Blind intubation, 163 Carbon dioxide elimination (VCO 2 ), 297
Blood flow, pulmonary, 32–34 Cardiac arrest, 503–504
Blood gases. See Arterial blood gases (ABGs) Cardiac index (C.I.), 291–292
Blood pressure Cardiac output, 284
changes, during positive pressure ventilation, 31 decrease in, 31, 232–233, 253
decrease in, 232–233 Fick’s estimated method, 689–690
monitoring, 243–244 Lithium Dilution Cardiac Output (LiDCO),
Blood urea nitrogen (BUN), 37t 296
Body temperature, 245–246 mean airway pressure and, 30, 31f
Body water, distribution of, 400–401, 401t measurement, 291–292
Botulism case study, 667–671 Pulse Contour Cardiac Output (PiCCO), 296
Boyle’s Law, 598 Cardiac pacing, 599, 601
Brachial plexopathy, 410 Cardiovascular decompensation, 20t
Bradycardia, 243 Cardiovascular effects, of opioids, 445–446
Brain, Archie, 133 Case study
Brain herniation, 504 acute respiratory distress syndrome, 649–655
Brain injury. See Traumatic brain injury (TBI) botulism, 667–671
Breath sequence, 85t chest trauma, 644–649
Breath sounds COPD, 616–620
abnormal, 248t drug overdose, 635–639
auscultation of, 248–249 end-of-life sedation, 685–687
Bronchial alveolar lavage (BAL), 471t Guillain-Barré, 660–667
Bronchial brushing, 475–476 head injury, 628–631
Bronchial toilet, 471t home care and disease management, 678–685
Bronchodilators, 422, 423 meconium aspiration/patent ductus arteriosus,
adrenergic (sympathomimetics), 423–426 672–676
anticholinergic (parasympatholytics), 426t myasthenia gravis, 656–660
delivery of, 430–431 persistent pulmonary hypertension, 676–678
xanthine, 427–429, 428t post-abdominal surgery, 625–628
Bronchoscope, 472–473 smoke inhalation, 631–635
Bronchoscopy status asthmaticus, 620–625
complications of, 476–477 tension hemopneumothorax, 639–644
diagnostic, 470 Catabolism, 42
fiberoptic, 470–477 Catecholamine derivatives, 424–425, 425t
flexible, 471–472t, 473 Catecholamines, 424, 425t
medications, 472–473, 473t Catechol-O-methyltransferase (COMT), 424, 425
specimen collection, 473, 475–476 Catheters
therapeutic, 470, 472 arterial, 277–281
Bronchovideoscope, 474f central venous, 281–284
BUN to creatinine ratio, 37t pulmonary artery, 284–292

Copyright 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part. Due to electronic rights, some third party content may be suppressed from the eBook and/or eChapter(s).
Editorial review has deemed that any suppressed content does not materially affect the overall learning experience. Cengage Learning reserves the right to remove additional content at any time if subsequent rights restrictions require it.